 |
|
Low Testosterone Levels and the Risk of Anemia in Older Men and Women
Luigi Ferrucci, MD, PhD;
Marcello Maggio, MD;
Stefania Bandinelli, MD;
Shehzad Basaria, MD;
Fulvio Lauretani, MD;
Alessandro Ble, MD;
Giorgio Valenti, MD;
William B. Ershler, MD;
Jack M. Guralnik, MD, PhD;
Dan L. Longo, MD
Arch Intern Med. 2006;166:1380-1388.
Background Anemia is a frequent feature of male hypogonadism and anti-androgenic treatment. We hypothesized that the presence of low testosterone levels in older persons is a risk factor for anemia.
Methods Testosterone and hemoglobin levels were measured in a representative sample of 905 persons 65 years or older without cancer, renal insufficiency, or anti-androgenic treatments. Hemoglobin levels were reassessed after 3 years.
Results At baseline, 31 men and 57 women had anemia. Adjusting for confounders, we found that total and bioavailable testosterone levels were associated with hemoglobin levels in women (P = .001 and P = .02, respectively) and in men (P<.001 and P = .03, respectively). Men and women in the lowest quartile of total and bioavailable testosterone were more likely than those in the highest to have anemia (men, 14/99 vs 3/100; odds ratio [OR], 5.4; 95% confidence interval [CI], 1.4-21.8 for total and 16/99 vs 1/99; OR, 13.1; 95% CI, 1.5-116.9 for bioavailable testosterone; women, 21/129 vs 12/127; OR, 2.1; 95% CI, 0.9-5.0 for total and 24/127 vs 6/127; OR, 3.4; 95% CI, 1.2-9.4 for bioavailable testosterone). Among nonanemic participants and independent of confounders, men and women with low vs normal total and bioavailable testosterone levels had a significantly higher risk of developing anemia at 3-year follow-up (21/167 vs 28/444; relative risk, 2.1; 95% CI, 1.1-4.1 for total and 26/143 vs 23/468; relative risk, 3.9; 95% CI, 1.9-7.8 for bioavailable testosterone).
Conclusion Older men and women with low testosterone levels have a higher risk of anemia.
Author Affiliations: Clinical Research Branch, National Institute on Aging, Baltimore, Md (Drs Ferrucci, Maggio, Ble, Ershler, and Longo); Azienda Sanitaria Firenze, Geriatric Rehabilitation, Florence, Italy (Dr Bandinelli); Department of Medicine, Division of Endocrinology, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore (Dr Basaria); Tuscany Regional Health Agency, Florence (Dr Lauretani); Department of Internal Medicine and Biomedical Sciences, Geriatric Section, University of Parma, Parma, Italy (Dr Valenti); and Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Bethesda, Md (Dr Guralnik).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Radiation-induced hypopituitarism
Fernandez et al.
Endocr Relat Cancer 2009;16:733-772.
ABSTRACT
| FULL TEXT
Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero et al.
J. Am. Soc. Nephrol. 2009;20:613-620.
ABSTRACT
| FULL TEXT
Association Between Serum Bioavailable Testosterone Concentration and the Ratio of Glycated Albumin to Glycated Hemoglobin in Men With Type 2 Diabetes
Fukui et al.
Diabetes Care 2008;31:397-401.
ABSTRACT
| FULL TEXT
Low Serum Testosterone and Mortality in Older Men
Laughlin et al.
J. Clin. Endocrinol. Metab. 2008;93:68-75.
ABSTRACT
| FULL TEXT
Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older Men: The Aging in the Chianti Area (InCHIANTI) Study
Maggio et al.
Arch Intern Med 2007;167:2249-2254.
ABSTRACT
| FULL TEXT
Anemia in the Elderly: How Should We Define It, When Does It Matter, and What Can Be Done?
Steensma and Tefferi
Mayo Clin Proc. 2007;82:958-966.
ABSTRACT
| FULL TEXT
|
